The approval of an MDMA drug trial for individuals suffering from post-traumatic stress disorder (PTSD) offers hope for a potential medical breakthrough in treating this debilitating condition.
This initiative aimed to provide respite, rehabilitation, and emotional support to soldiers grappling with the psychological aftermath of warfare and trauma.
Post-Traumatic Stress Disorder (PTSD) is a pressing issue affecting many military personnel, including the brave men and women serving in the Israeli Defense Forces (IDF).
'These numbers stem from another terror-ridden summer that saw hundreds of rockets being fired toward the area from the Hamas-controlled enclave,' reports Ynet.